ASML vs DNTH · P/E 57, $665.37B cap vs rev $6.2M
ASML Holding NV ADR (ASML) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
ASML does not have a complete income-statement cache yet.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the ASML and DNTH stock pages for the full models.
Not investment advice.